



















Welcome to our dedicated page for Applied DNA Sciences news (Ticker: APDN), a resource for investors and traders seeking the latest updates and insights on Applied DNA Sciences stock.. Applied DNA Sciences, Inc. (NASDAQ: APDN) is a biotechnology company pioneering advanced DNA-based technologies to safeguard …







Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.









Applied DNA Sciences Inc's profitability metrics reveal strong financial health. The company currently boasts an operating margin of -439.20% and a profit margin of -221.34%, with a gross margin of -82.95%. The profit margin, also known as the revenue ratio or gross profit ratio, measures how efficiently a company converts sales into net ...



















Applied DNA Sciences: Fiscal Q3 Earnings Snapshot. STONY BROOK, N.Y. (AP) — Applied DNA Sciences Inc. APDN) on Thursday reported fiscal third-quarter net income of $1.9 million, after reporting a loss in the same period a year earlier. On a per-share basis, the Stony Brook, New York-based company said it had profit of 47 cents.










